The latest trend in metabolic health is undoubtedly centered around GLP-1 therapies, and BrightMeds is leading this wave . These powerful drugs, initially developed for treating type 2 diabetes, are now increasingly prescribed – or considered – for their remarkable ability to promote reduced body